Experienced in Heart Failure with Preserved Ejection Fraction (HFpEF)

Maximilian V. Malfertheiner

Franz Josef Strauss Allee 11, 
Regensburg, BY, DE 
Experienced in Heart Failure with Preserved Ejection Fraction (HFpEF)
Franz Josef Strauss Allee 11, 
Regensburg, BY, DE 
OverviewLocationsClinical Research

Overview

Maximilian Malfertheiner practices in Regensburg, Germany. Mr. Malfertheiner is rated as an Experienced expert by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). His top areas of expertise are Central Sleep Apnea, Respiratory Acidosis, Acute Respiratory Distress Syndrome (ARDS), and Cerebral Hypoxia.

His clinical research consists of co-authoring 78 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Heart Failure with Preserved Ejection Fraction (HFpEF).

Gender
Male

Locations

Franz Josef Strauss Allee 11, Regensburg, BY 93053, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Advancing Brigatinib Properties in Anaplastic Lymphoma Kinase Positive Non-small Cell Lung Cancer (ALK+ NSCLC) Patients
Advancing Brigatinib Properties in Anaplastic Lymphoma Kinase Positive Non-small Cell Lung Cancer (ALK+ NSCLC) Patients
Enrollment Status: Active_not_recruiting
Publish Date: October 15, 2024
Intervention Type: Drug
Study Drugs: Brigatinib, Tyrosine kinase inhibitor
Study Phase: Phase 2
Percutaneous Temporary Placement of a Phrenic Nerve Stimulator for Diaphragm Pacing
Percutaneous Temporary Placement of a Phrenic Nerve Stimulator for Diaphragm Pacing
Enrollment Status: Completed
Publish Date: November 16, 2022
Intervention Type: Device
Study Phase: Not Applicable
View 1 Less Clinical Trial

78 Total Publications

A rare manifestation of a cystic lung disease with high suspicion of pulmonary light chain deposition disease (LCDD)
A rare manifestation of a cystic lung disease with high suspicion of pulmonary light chain deposition disease (LCDD)
Journal: Pneumologie (Stuttgart, Germany)
Published: September 23, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Malfertheiner's expertise for a condition
ConditionClose
      View All 16 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile